Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.245 SEK
−37.07 M SEK
721.00 K SEK
143.45 M
About ISOFOL MEDICAL AB
Sector
CEO
Petter Segelman Lindqvist
Headquarters
Gothenburg
Website
Founded
2008
ISIN
SE0009581051
FIGI
BBG00GCR2NK6
Isofol Medical AB is a biotech company, which engages in the development of the cancer drug Arfolitixorin, intended primarily for the treatment of colorectal cancer. The company was founded in 2008 by Bengt Gustaf Gustavsson and is headquartered in Gothenburg, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ISOFOL is 2.340 SEK — it has decreased by −2.70% in the past 24 hours. Watch ISOFOL MEDICAL AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ISOFOL MEDICAL AB stocks are traded under the ticker ISOFOL.
ISOFOL stock has fallen by −0.21% compared to the previous week, the month change is a −22.00% fall, over the last year ISOFOL MEDICAL AB has showed a 320.11% increase.
ISOFOL reached its all-time high on Jan 12, 2021 with the price of 26.480 SEK, and its all-time low was 0.450 SEK and was reached on Dec 8, 2023. View more price dynamics on ISOFOL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ISOFOL stock is 4.57% volatile and has beta coefficient of 2.24. Track ISOFOL MEDICAL AB stock price on the chart and check out the list of the most volatile stocks — is ISOFOL MEDICAL AB there?
Today ISOFOL MEDICAL AB has the market capitalization of 377.94 M, it has increased by 2.78% over the last week.
Yes, you can track ISOFOL MEDICAL AB financials in yearly and quarterly reports right on TradingView.
ISOFOL MEDICAL AB is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
ISOFOL net income for the last quarter is −10.86 M SEK, while the quarter before that showed −11.04 M SEK of net income which accounts for 1.68% change. Track more ISOFOL MEDICAL AB financial stats to get the full picture.
No, ISOFOL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 3.00 employees. See our rating of the largest employees — is ISOFOL MEDICAL AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ISOFOL MEDICAL AB EBITDA is −43.30 M SEK, and current EBITDA margin is −5.80 K%. See more stats in ISOFOL MEDICAL AB financial statements.
Like other stocks, ISOFOL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ISOFOL MEDICAL AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ISOFOL MEDICAL AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ISOFOL MEDICAL AB stock shows the neutral signal. See more of ISOFOL MEDICAL AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.